Traditionally, it was considered that the first detectable mineral metabolism abnormality in CKD patients that might explain the onset of hyperparathyroidism was the increase in serum phosphate, which determined hypocalcemia, the decrease in calcitriol, and consequently the augmentation of PTH values [8]. This evidence concerns the gene PTH and chronic kidney disease.